For patienter, som fik 50 mg én gang om ugen i hele underøgelsen, fortsatte effekt- responsen med at forbedres, så 71% opnåede PASI 75 i uge 24.
For patients who received 50 mg once weekly throughout the study, the efficacy responses continued to improve with 71% achieving PASI 75 at week 24.